Sprache:
Cara Care Startseite

Enable your GERD- or indigestion patients exclusive access to a digital therapy as part of our studies

Studies in preparation

*Therapy is currently only available in German.

    Header Image

    Study information

    We aim to investigate in two parallel pilot studies whether an app can effectively support the conventional therapy of GERD and functional dyspepsia (indigestion).

    The objective of the studies is to collect initial data on the hypothesis that Cara Care for heartburn and stomach discomfort can alleviate symptoms more effectively than the respective standard treatment alone.

      Study objectives: Evaluation of a digital therapy for gastroesophageal reflux disease (GERD) and functional dyspepsia (indigestion) with Cara Care for heartburn and stomach complaints (CE-marked medical device).

      Duration of the intervention: 12 weeks

      Design: Non-invasive, not additionally burdensome, multicentric, prospective, two-arm, randomized studies with parallel group design

      Number of patients: GERD: 264 • Functional Dyspepsia: 185

      Benefits of Cara Care for heartburn and stomach discomfort

      A win-win situation for you and your patients.

      • Benefits for your patients

        Patient illustration
        • Patients receive a compensation of up to 80 € in vouchers for full participation in the study.
        • Control group participants get access to the full app for another 3 months after 12 weeks.
        • By participating in one of our studies, patients help others affected
      • Your benefits

        Doctor illustration
        • You support innovative scientific progress.
        • No extra effort for you as a recruiting doctor, as patients go through the therapy independently.
        • You receive a compensation for included participants.

      Recording of diet, symptoms, and well-being.

      Tracking & diary

      Patients can record their diet and symptoms as well as many other factors to identify correlations and trigger factors.
      Feature Bild

      We meet the highest standards for digital therapy.

      Quality

      • Strictest data protection GDPR-compliant & encrypted health data

      • Scientifically based Developed by experts

      • Official medical device Medical device of risk class 1 according to MDR

      • Medically up-to-date Based on the latest medical guidelines

       

      Our scientific leadership

      Board

      • Medical Director

        Linda Weißer

      • Facharzt für Innere Medizin und Gastroenterologie/Hepatologie

        Prof. Dr. med. Joachim Labenz

      What are you waiting for?

      We accompany you step by step on your way to noticeably fewer irritable bowel problems

      We meet the highest standards for digital therapy.

      Quality

      • Diseases

        Exploring Gut-Related Disorders and Their Impact on Overall Health

      • Treatment

        Effective Approaches to Restore and Maintain Gut Health

      • Nutrition

        Nutritional Strategies and Recipes for Optimal Digestive Wellness

      • Diagnostics

        Understanding Diagnostic Tools for Assessing Gut Health

      CE-certified medical device

      data protection guaranteed